Very good result. I'm shocked LFL sales for July and August are down only under 2% ... How they got a better LFL than Lovisa boggles my mind. Either they're doing really well or something wrong with Lovisa. I think it's the former .
- Forums
- ASX - By Stock
- AX1
- Ann: FY23 Full-Year Investor Presentation
Ann: FY23 Full-Year Investor Presentation, page-6
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AX1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.35 |
Change
0.025(1.08%) |
Mkt cap ! $1.321B |
Open | High | Low | Value | Volume |
$2.32 | $2.37 | $2.31 | $1.125M | 479.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 25953 | $2.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.35 | 9587 | 23 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
39 | 16605 | 2.350 |
22 | 27297 | 2.340 |
17 | 38066 | 2.330 |
12 | 26803 | 2.320 |
19 | 155715 | 2.310 |
Price($) | Vol. | No. |
---|---|---|
2.360 | 10573 | 24 |
2.370 | 56623 | 18 |
2.380 | 99072 | 21 |
2.390 | 63491 | 19 |
2.400 | 211451 | 28 |
Last trade - 13.08pm 11/10/2024 (20 minute delay) ? |
Featured News
AX1 (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online